Protein Summary
Cytokine which is involved in epithelial-mesenchymal signaling during morphogenesis of ectodermal organs. Functions as a ligand activating the DEATH-domain containing receptors EDAR and EDA2R (PubMed:8696334, PubMed:11039935, PubMed:27144394). May also play a role in cell adhesion (By similarity). Isoform 1: Binds only to the receptor EDAR, while isoform 3 binds exclusively to the receptor EDA2R. Isoform 3: Binds only to the receptor EDA2R. The protein encoded by this gene is a type II membrane protein that can be cleaved by furin to produce a secreted form. The encoded protein, which belongs to the tumor necrosis factor family, acts as a homotrimer and may be involved in cell-cell signaling during the development of ectodermal organs. Defects in this gene are a cause of ectodermal dysplasia, anhidrotic, which is also known as X-linked hypohidrotic ectodermal dysplasia. Several transcript variants encoding many different isoforms have been found for this gene. [provided by RefSeq, Jul ...more
- ENST00000338901
- ENSP00000340611
- ENSG00000158813
- ENST00000374552
- ENSP00000363680
- ENST00000374553
- ENSP00000363681
- ENST00000524573
- ENSP00000432585
- ENST00000525810
- ENSP00000434195
- ENST00000527388
- ENSP00000434861
- ED1
- EDA2
- ED1
- HED
- EDA1
- EDA2
- HED1
- ODT1
- XHED
- ECTD1
- XLHED
- ED1-A1
- ED1-A2
- EDA-A1
- EDA-A2
- TNLG7C
- STHAGX1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
disease perturbation | 0.83 | ||
biological process | 0.75 | ||
cellular component | 0.73 | ||
phenotype | 0.66 | ||
biological term | 0.63 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 350.34 (req: < 5)
Gene RIFs: 97 (req: <= 3)
Antibodies: 489 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 350.34 (req: >= 5)
Gene RIFs: 97 (req: > 3)
Antibodies: 489 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 21
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0